HOFSETH BIOCARE ASA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.09 NOK | -0.48% |
|
-2.79% | -20.23% |
| 03-14 | Hofseth BioCare ASA Announces Board Changes | CI |
| 02-09 | Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
| Sales 2022 | 120M 10.93M 874M | Sales 2023 | 219M 19.82M 1.59B | Capitalization | 1.04B 93.89M 7.51B |
|---|---|---|---|---|---|
| Net income 2022 | -137M -12.43M -994M | Net income 2023 | -107M -9.71M -776M | EV / Sales 2022 | 11.4 x |
| Net Debt 2022 | 71.74M 6.51M 520M | Net Debt 2023 | 257M 23.3M 1.86B | EV / Sales 2023 | 5.91 x |
| P/E ratio 2022 |
-8.89
x | P/E ratio 2023 |
-9.7
x | Employees | 70 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 41.78% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.48% | ||
| 1 week | -2.79% | ||
| Current month | +0.48% | ||
| 1 month | -0.48% | ||
| 3 months | -18.99% | ||
| 6 months | -25.36% | ||
| Current year | -20.23% |
1 week
2.00
2.20
1 month
1.902.23
Current year
1.902.76
1 year
1.903.95
3 years
1.908.80
5 years
1.9010.95
10 years
1.1210.95
| Managers | Title | Age | Since |
|---|---|---|---|
Jon Olav Ødegård
CEO | Chief Executive Officer | 51 | 28/02/13 |
Roger Hofseth
CEO | Chief Executive Officer | 50 | 31/12/99 |
Crawford Currie
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Roger Hofseth
CEO | Chief Executive Officer | 50 | 31/12/99 |
| Director/Board Member | 53 | 30/04/15 | |
| Director/Board Member | 49 | 30/04/15 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 2.09 | -0.48% | 43,478 |
| 25/04/24 | 2.1 | -4.55% | 101,046 |
| 24/04/24 | 2.2 | +0.46% | 4,265 |
| 23/04/24 | 2.19 | -0.45% | 893 |
| 22/04/24 | 2.2 | +2.33% | 3,196 |
Real-time Oslo Bors, April 26, 2024 at 03:45 pm
More quotes
Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Companyâs business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
Sector
Food Processing
Calendar
10/05/2024
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -20.23% | 74.77M | |
| -4.93% | 261B | |
| -2.51% | 94.98B | |
| +3.19% | 46.39B | |
| +8.74% | 39.99B | |
| -0.65% | 39.95B | |
| -0.15% | 38.02B | |
| -16.78% | 30.16B | |
| -6.61% | 28.72B | |
| +11.32% | 24.54B |
- Stock Market
- Equities
- HBC Stock
